Inhaled Corticosteroids Versus Observation for Patients With Decreased Lung Function Status

Stopped early · Phase 2

Conditions studied: Bronchiolitis

In brief

The goal of this clinical research study is to compare lung function of patients who inhale steroids in the early stages of post-transplant constrictive bronchiolitis (PTCB) to patients who continue with standard of care.

Key facts

Study ID

NCT00656916

Run by

M.D. Anderson Cancer Center

People needed

1

Starts

2008-03-01

Expected to finish

2010-12-01

Last updated by the study team

2012-04-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients >/=18 years of age.
• Patients must be engrafted and at least 80 days post allogeneic hematopoietic stem cell transplantation.
• New onset airflow obstruction defined as decline of forced expiratory volume in 1 second (FEV1) percent predicted >/= 15%.
• Total Lung Capacity (TLC) > 85% to rule out restrictive lung disease.
• Patient must be willing to comply with all study procedures and capable of signing informed consent.

You may not qualify if…

• Patients with active pulmonary infection.
• Patients with known hypersensitivity to corticosteroids

Where it is running

• UT MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.